Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2026-02-24 @ 5:50 AM
Study NCT ID:
NCT02260193
Status:
COMPLETED
Last Update Posted:
2022-07-01
First Post:
2014-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
Sponsor:
Akebia Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AKB-6548-CI-0011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None